Yoon-Kyoung Cho,
Professor, Biomedical Engineering and Dean,
UNIST (Ulsan National Institute of Science & Technology)
Yoon-Kyoung Cho is currently a full professor in Biomedical Engineering and the dean of College of Information and Biotechnology at UNIST, Republic of Korea. She is a member of the National Academy of Engineering of Korea (NAEK), an associate editor of the journal ‘Lab on a chip’, a fellow of the Royal Society of Chemistry, and vice president of the Chemical and Biological Microsystems Society (CBMS). She earned her Ph.D. in Materials Science and Engineering from the University of Illinois at Urbana-Champaign in 1999, following her M.S. and B.S. in Chemical Engineering from POSTECH in 1994 and 1992, respectively. Prior to joining UNIST in 2008, she served as a senior researcher (1999–2008) at Samsung Advanced Institute of Technology (SAIT). Her current research focuses on lab-on-a-chip systems for detecting rare biomarkers, quantitative analysis of cell migration, and systems analysis of intercellular communication. Discover more at http://fruits.unist.ac.kr. https://scholar.google.com/citations?user=Jc1mz_EAAAAJ&hl=en
Lab-on-a-Disc For Precision Medicine
Monday, 18 March 2024 at 17:00
Add to Calendar ▼2024-03-18 17:00:002024-03-18 18:00:00Europe/LondonLab-on-a-Disc For Precision MedicineEmerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Liquid biopsy is a promising alternative to tissue biopsy for cancer clinics, as it can provide valuable information on circulating biomarkers and aid in treatment planning for individual patients. However, the process can be expensive, complex, and requires large sample volumes, with low sensitivity being a significant limitation. To address these challenges, we have developed "lab-on-a-disc" systems that utilize centrifugal force to analyze cancer-related biomarkers in biological fluids such as blood or urine. Our system can isolate and detect liquid biopsy markers such as circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs). We have tested our system using clinical samples from cancer patients and are excited to introduce our fluid-assisted separation technology, which allows for fast, uniform, clog-free, and efficient filtration. Additionally, we will discuss our recent studies on the potential of extracellular vesicles (EVs) as cancer biomarkers, which could have significant implications for cancer diagnostics. In addition, we will introduce a hand-powered centrifugal bacterial isolation device to determine the bacterial load and to test antibiotics susceptibility which is designed for the usage in resource-limited settings. We believe that our innovative microfluidic tools can accelerate the translation of liquid biopsy technology into real clinical settings, directly impacting patient care.
Add to Calendar ▼2024-03-18 00:00:002024-03-19 00:00:00Europe/LondonEmerging Technologies and Paradigms for In Vitro Dx Europe 2024Emerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2024-03-18 17:00:002024-03-18 18:00:00Europe/LondonLab-on-a-Disc For Precision MedicineEmerging Technologies and Paradigms for In Vitro Dx Europe 2024 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
